Characteristics of neuroimaging findings in the study groups
| Variables | Total n=170 | LR-patients n=43 | M/HR-patients n=127 | χ2 (p value) | |
| Lacunes | 14 (8.2) | 2 (4.6) | 12 (9.4) | 1.0 (0.32) | |
| Microbleeds | 5 (2.9) | 0 | 5 (3.9) | 1.7 (0.2) | |
| PVS | 116 (68.2) | 27 (62.8) | 89 (70.1) | 0.8 (0.4) | |
| WMH Fazekas modified score | 0 | 58 (34.1) | 24 (55.8) | 34 (26.8) | 9.7 (0.00) |
| 1 | 57 (33.5) | 13 (30.2) | 44 (34.6) | ||
| 2 | 38 (22.4) | 4 (9.3) | 34 (26.8) | ||
| 3 | 17 (10) | 2 (4.7) | 15 (11.8) | ||
| Global CSVD Score | 0 | 28 (16.5) | 9 (20.9) | 19 (15) | 9.6 (0.04) |
| 1 | 54 (31.8) | 20 (46.5) | 34 (26.8) | ||
| 2 | 74 (43.5) | 14 (32.6) | 60 (47.2) | ||
| 3 | 12 (7) | 0 | 12 (9.4) | ||
| 4 | 2 (1.2) | 0 | 2 (1.6) | ||
| Global CSVD severity | 0–1 | 83 (48.8) | 29 (67.4) | 54 (42.5) | 6.6 (0.01) |
| 2–4 | 87 (51.2) | 14 (32.6) | 73 (57.5) | ||
CSVD, cerebral small vessel disease; LR, low risk; M/HR, moderate/high-risk; PVS, perivascular spaces; WMH, white matter hyperintense.